Opendata, web and dolomites

iMOTED SIGNED

iMOTED Platform Built to improve Clinical Trial outcomes

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 iMOTED project word cloud

Explore the words cloud of the iMOTED project. It provides you a very rough idea of what is the project "iMOTED" about.

multiple    delay    whom    time    customizable    belongs    software    hence    huge    complexity    cumulative    prove    tested    asking    amount    registered    trial    upwards    31    simplify    marketing    considering    560    bn    opportunity    safe    reduce    licenses    believe    sponsors    return    launch    near    12    usually    countries    80    companies    investigators    collected    point    estimations    perform    2017    ct    costing    industry    forecasted    economic    marketed    alarms    2024    therapy    platform    losses    drug    device    feasibility    spend    simulations    beginning    designed    individuals    revenues    carg    day    intuitive    body    launching    roi    breakeven    initially    turnover    business    drugs    predictions    140    2022    generation    ec    sources    rate    give    pharma    imoted    market    exceed    period    trials    clinical    human    13    start    data       120    inefficient    employing    domestic    clinic    stage    quality    selling    delayed    interface   

Project "iMOTED" data sheet

The following table provides information about the project.

Coordinator
BIODATUP SL 

Organization address
address: PASEO MIKELETEGUI 83
city: SAN SEBASTIAN DONOSTIA
postcode: 20009
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://biodatup.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIODATUP SL ES (SAN SEBASTIAN DONOSTIA) coordinator 50˙000.00

Map

 Project objective

Clinical Trials (CT) are designed to prove if a drug, device or therapy is safe and effective in the human body, so they are already tested in individuals. The CT investigators and sponsors spend great amount of resources on data management and project and data quality control. In 2017 more than 120,000 CT have been registered, of which near 31,000 are carried out in the EU. Usually the average duration of CT from start to marketing is 7.5 years, however, more than 80% of CT are delayed from 1 to 6 month costing to the companies upwards of 30,000 € per day per trial. In most of the cases, this delay is due to inefficient management systems. With CT conducted in over 140 countries, the complexity and rate of change in trials is increasing. Considering this huge business opportunity, we have been working in a customizable software system to manage and simplify CT development. iMOTED platform will ensure high quality data, collected from multiple sources by using real time analysis of data, a simple and intuitive interface, generation of real time alarms employing estimations, predictions & simulations In this way, we expect to reduce the economic losses that pharma industry has when launching a new drug, for whom only 2 out of 10 marketed drugs return revenues that exceed R&D costs. iMOTED belongs to the e-clinic market, which is forecasted to reach €7.6 Bn by 2022 growing at a CARG of 12.4% over the period 2017-2022. We will initially target Europe as our domestic market, to start selling the IMOTED licenses. We expect to have our breakeven point two years after the beginning of the project, a cumulative turnover of €13 M by 2022, that will give us a ROI of 560% in 2024. Hence, at this stage of development we believe that we need to perform a through feasibility study to assess for the challenges and tasks that we still must accomplish to launch iMOTED for what we are asking for EC support.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IMOTED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IMOTED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Savesight (2020)

Contact lens embedded sensor for ocular hypertension and glaucoma monitoring

Read More  

ALR4000 (2019)

Automated LCD Recycling series 4000

Read More  

LOLAS (2019)

Precise and reliable autonomous landing for drones, helicopters and other rotorcraft

Read More